Contact our breast care nurses
0808 800 6000
Overall survival for male breast cancer patients is improving - but not as fast as for females with the disease, according to the results of one of...
In response to new research showing that 78% of people diagnosed with breast cancer will live longer than ten years compared with 40% in the early...
Katherine Woods, Senior Research Communications Manager at Breast Cancer Campaign, comments: “This trial has produced some...
Yesterday NICE announced they are updating their guidance to better support GPs and other primary healthcare professionals and ultimately...
Baroness Delyth Morgan, Chief Executive of Breast Cancer Campaign, said: "We know that the earlier cancer is diagnosed and treated, the greater...
The stats show that even though the target for the two-week wait for suspected breast cancer has been met, more people than ever with suspected...
Baroness Delyth Morgan, Chief Executive of Breast Cancer Campaign, said: “The report released today by Macmillan confirms how much there is...
In response to yesterday's announcement that many breast cancer medicines including Perjeta Kadcyla and Eribulin are up for re-evaluation within...
The Scottish Medicines Consortium has announced today that Pertuzumab (Perjeta) is not recommended for use within NHS Scotland for patients with...
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.
Sign up
Connect with us
